Analyst firms · Raymond James · PHR
Raymond James PHR price target and rating history
Phreesia Inc. (PHR) · Consumer Discretionary
Raymond James rates Phreesia Inc. (PHR) Mkt Perform with a $55 price target, as of its latest action on Sep 8, 2026. It has published 3 rating actions on PHR since September 2021, including 0 upgrades and 1 downgrade. Across 8 firms with a PHR price target in the last 12 months, the median target is $10.50.
- Current rating
- Mkt Perform
- Price target
- $55
- Median target, all firms
- $10.50
- Actions on PHR
- 3
Raymond James price target on PHR
Every Raymond James rating on PHR
- Sep 8, 2026
- Dec 14, 2021
- Sep 3, 2021
How other firms rate PHR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Raymond James | Mkt Perform | Sep 8, 2026 | |
| Piper Sandler | Neutral | $12 | May 28, 2026 |
| Wells Fargo | Equal Weight | $9 | May 20, 2026 |
| Barclays | Equal Weight | $10 | May 15, 2026 |
| Citizens JMP | Mkt Perform | Apr 1, 2026 | |
| Robert W. Baird | Neutral | $10 | Mar 31, 2026 |
| Truist Securities | Hold | $11 | Mar 31, 2026 |
| Citigroup | Neutral | $10 | Mar 31, 2026 |
| Needham | Buy | $14 | Mar 31, 2026 |
| RBC Capital Markets | Outperform | $26 | Jan 9, 2026 |
Questions about Raymond James and PHR
- What is Raymond James's price target for PHR?
- Raymond James's latest stated price target for Phreesia Inc. (PHR) is $55, from its action on Dec 14, 2021.
- What is Raymond James's rating on PHR?
- Raymond James rates PHR Mkt Perform, a neutral rating, as of Sep 8, 2026.
- When did Raymond James last change its view on PHR?
- On Sep 8, 2026, Raymond James downgrades to Mkt Perform from Outperform.
- How does Raymond James's PHR target compare with other analysts?
- Across 8 firms with a PHR price target in the last 12 months, the median target is $10.50.
More PHR rating histories
All Raymond James ratingsPHR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.